Novavax appoints Rick Rodgers as new Independent director Ruchika Sharma5 Nov 2022 4:06 PM ISTGaithersburg: Novavax, Inc. has announced the appointment of Richard Rodgers, MBA to its board as an independent director. Mr. Rodgers brings...
USFDA grants emergency use nod for Novavax COVID vaccine,Adjuvanted as booster for adults Ruchika Sharma20 Oct 2022 5:46 PM ISTGaithersburg: Novavax, Inc. has announced that the company's COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA)...
Novavax seeks updated Emergency Use Listing from WHO for Nuvaxovid as booster in adults Ruchika Sharma18 Sept 2022 12:30 PM ISTUS: Novavax has announced the submission of a request to the World Health Organization (WHO) to update the Emergency Use Listing (EUL) of Nuvaxovid...
Novavax Nuvaxovid gets expanded conditional marketing authorization in EU for use as booster for adults aged 18 and older Ruchika Sharma14 Sept 2022 1:15 PM ISTGaithersburg: Biotechnology company, Novavax, Inc., has recently announced that the European Commission (EC) has approved the expanded conditional...
SII, Novavax report full product registration in South Africa of COVID jab NVX-CoV2373 for adults aged 18 and older Ruchika Sharma14 Sept 2022 12:20 PM ISTGaithersburg: Novavax, Inc., a biotechnology company and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by...
Novavax COVID vaccine Nuvaxovid gets expanded conditional marketing nod in UK for adolescents aged 12 through 17 Ruchika Sharma27 Aug 2022 11:15 AM ISTGaithersburg: Novavax, Inc. has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has granted...
Novavax COVID vaccine Nuvaxovid gets provisional nod in New Zealand for adolescents aged 12 through 17 Ruchika Sharma22 Aug 2022 1:45 PM ISTNuvaxovid (NVX-CoV2373) is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes...
Novavax COVID vaccine Adjuvanted gets USFDA emergency use authorization for adolescents aged 12 through 17 Ruchika Sharma22 Aug 2022 12:15 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID jab shows high levels of protection against infection in two large phase-3 trials Ruchika Sharma18 Aug 2022 2:29 PM ISTDr Glenn further said the study was conducted with a vaccine based on the original Wuhan spike protein sequence.
Novavax tumbles 31 percent as waning COVID vaccine demand hits revenue forecast Ruchika Sharma12 Aug 2022 1:00 PM ISTBut only 7,381 Novavax vaccine doses have been administered so far in the country, with Chief Executive Stanley Erck saying that its late launch could...
Novavax COVID shot Nuvaxovid must carry warning of heart inflammation, recommends EU Ruchika Sharma4 Aug 2022 12:59 PM IST"We will work with the relevant regulators to assure our product information is consistent with our common interpretation of the incoming data," U.S....
COVID vaccine: Novavax requests WHO to expand Emergency Use Listing of Nuvaxovid for adolescents aged 12 through 17 Ruchika Sharma1 Aug 2022 3:25 PM ISTThe WHO previously granted EUL for Nuvaxovid in adults aged 18 and older in December 2021.
